Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CD19 anticorps (PE)

Cet anticorps anti-CD19 est un anticorps Souris Monoclonal détectant CD19 dans FACS. Adapté pour Humain.
N° du produit ABIN2144814

Aperçu rapide pour CD19 anticorps (PE) (ABIN2144814)

Antigène

Voir toutes CD19 Anticorps
CD19 (CD19 Molecule (CD19))

Reactivité

  • 355
  • 189
  • 47
  • 32
  • 19
  • 13
  • 6
  • 5
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Humain

Hôte

  • 249
  • 128
  • 81
  • 6
  • 4
  • 4
  • 2
Souris

Clonalité

  • 351
  • 112
  • 6
Monoclonal

Conjugué

  • 141
  • 28
  • 27
  • 26
  • 23
  • 13
  • 9
  • 9
  • 9
  • 8
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Cet anticorp CD19 est conjugé à/à la PE

Application

  • 353
  • 123
  • 81
  • 70
  • 68
  • 65
  • 29
  • 20
  • 20
  • 14
  • 14
  • 13
  • 11
  • 10
  • 5
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS)

Clone

4ACB19
  • Attributs du produit

    4ACB19 reacts with CD19 (B4), a 90 kDa molecule, which is expressed on approximately 5-25 % of human peripheral blood lymphocytes. CD19 antigen is present on human B lymphocytes at most stages of maturation, from the earliest Ig gene rearrangement in pro-B cells to mature cell, as well as malignant B cells, but is lost on maturation to plasma cells. CD19 antibody does not react with T lymphocytes, monocytes and granulocytes. CD19 is a critical signal transduction molecule that regulates B lymphocyte development, activation and differentiation. This clone is cross reactive with non-human primate.* CD19 is a key phenotyping marker of non-T cell leukemia.

    Isotype

    IgG1
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Procédure de l'essai

    • Take 100 μL peripheral blood anticoagulated by EDTA and add to the bottom of 5 mLtube,
    • Add 10 μL labeled antibody to the bottom of flow tube mixing with the whole blood, incubate for 20 minutes at room temperature away from light,
    • Add 2 ml1×RBC lysis buffer, incubate for 10 minutes away from light after mixing, dissolve red blood cells (recommended: RBC lysing Solution 10×,Cat.: FXP001),
    • Sample tube is set to 1000 rpm centrifugation for 5 minutes, discard the supernatant,
    • Add 2 mLPBS wash buffer to resuspend the cells, then1000 rpm centrifugation for 5 minutes, discard the supernatant,
    • Add 0.5 mLPBS wash buffer to resuspend the cells and detect by flow cytometry (sample should be determined on the day on the machine and can also be added fixation overnight at 4 °C then measured).
    • [PBS wash buffer: PBS +1 % FBS +0.1 % NaN3, Cat.: FXP005]
    • [Cell fixation: 2 % formaldehyde solution]

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Phosphate-buffered solution, pH 7.4, containing and 0.2 % (w/v) BSA

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C
  • Antigène

    CD19 (CD19 Molecule (CD19))

    Autre désignation

    CD19

    Pathways

    Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway
Vous êtes ici:
Chat with us!